IP — International Paper Company

Price action is unambiguously negative: as of 2026-09-13 the stock was down 7.73% in one week, 16.48% in one month, and 22-26% over the trailing year, with RSI at 30.07 and the shares 10-12% below every major moving average. The proximate causes are the late-July 2026 Q2 print (net sales -2.2% YoY to $6.00B, GAAP EPS -$0.02 despite a $0.04 adjusted beat), management's warning that diesel/fuel costs are tracking to a $150-200M drag, Canadian retaliatory tariffs on paper and packaging goods, and guidance that soft packaging demand persists into 2027. Analysts are more constructive than the tape (Buy consensus, $48.78-$50.14 average target from 9-16 analysts), but the market is clearly not paying for that recovery yet.

The three-year series shows a step-change, not a growth trend. Revenue ran $4.6-4.7B per quarter through 2023-2024, then jumped to $5.90B in Q1 2025 and peaked at $6.77B in Q2 2025 as DS Smith consolidated - and has since declined sequentially for four straight quarters ($6.22B, $6.01B, $5.97B) before flatlining at $6.00B in Q2 2026 (-2.2% YoY). Margin is the real story: pre-deal operating margins were 2.7-6.6%, but the last six quarters are -0.6%, 3.0%, -6.8%, -42.7%, 2.9%, 0.7%. The two catastrophic prints (Q3 2025 operating income -$426M, Q4 2025 -$2,565M; EPS -$2.09 and -$4.52) are almost certainly dominated by non-cash impairment and restructuring charges rather than cash losses, which is why the reported TTM numbers are so much worse than the underlying ~1-3% reported / high-single-digit underlying operating margin. This is a cyclical trough with integration noise on top - not a structural collapse - but there is no evidence of inflection yet; the best you can say is that the sequential bleed stopped in Q2 2026.

Valuation is genuinely two-sided as of 2026-09-13. The trailing P/E of -5.27 and PEG of -0.004 are meaningless because TTM EPS is -$6.49; price-to-book of 1.26x and price-to-sales of 0.752x (versus a five-year average P/S of 0.81) say the stock is modestly cheap on assets and sales, and the deterministic score flags it 'Cheap vs. its own history' (79.5/100). But on the forward number the market is paying up: $34.36 against next-FY consensus EPS of $1.362 is 25.2x, well above what a low-growth, 0.67x-debt-to-equity containerboard producer deserves. My normalized math - ~$2.65 of mid-cycle EPS on a 16.5% EBITDA margin - puts the stock at 13.0x, which is fair-to-cheap. The honest read: cheap if you underwrite the recovery, expensive if 2027 earnings actually land at $1.36.

IP is a textbook case of a stock trading on earnings that have not shown up yet rather than the ones on the tape. The sell-side's $48.78-$50.14 target cluster implies roughly $3.00-3.50 of normalized EPS at a 14-15x multiple - i.e. analysts are underwriting a full cyclical recovery plus successful EMEA separation, cost-out delivery, and fuel/tariff relief. Meanwhile management itself is guiding soft demand through 2027 and Q2 2026 adjusted EPS was $0.04. So the $34 price is doing two contradictory things: it has de-rated hard enough to reflect a genuinely poor near-term earnings run-rate, but it has not de-rated to trough-cyclical levels (10-12x forward) that would pay you for the wait. If Q3 2026 (late October) shows margin stabilization and cost-out traction, the gap between $34 and the high-$40s target compresses fast; if it shows another flat-to-down quarter, the 25x forward multiple has room to compress further.

As of 2026-09-13, IP's technicals are unambiguously bearish but approaching oversold: RSI(14) at 30.07, price 10.84% below the 20-day SMA, 12.39% below the 50-day, and 10.41% below the 200-day, with the shares at $34.36 versus a 52-week range of $29.26-$50.25. That is a stock in a confirmed downtrend with no base, no reclaim of any moving average, and momentum still bleeding - the -7.73% one-week and -16.48% one-month returns show selling accelerated into the analysis date, not exhausted. RSI at 30 is a bounce setup for traders, not a reversal signal for investors, and the shares still sit 17% above the 52-week low, so there is no capitulation-style valuation reset. Entry-timing implication: there is no technical reason to buy ahead of the late-October Q3 print - wait for either a close back above the 20-day SMA or a decisive flush toward the low $30s/high $20s where the dividend yield would do more of the work.

• Fuel and diesel cost inflation: management flagged a $150-200M headwind, a direct hit to freight-heavy containerboard economics that IP cannot fully pass through in a soft pricing environment.
• Trade friction: Canadian retaliatory tariffs on selected paper and packaging goods raise cross-border input and logistics costs across North American operations.
• Demand cycle: packaging demand recovery remains sluggish, with management projecting soft conditions through 2027 - box shipments are a real-time proxy for industrial and retail goods flow.
• Interest rates and leverage: post-DS Smith long-term debt sits at $8.22B (D/E 0.67) versus $5.5B pre-deal, so refinancing costs and interest expense are a persistent EPS drag in a higher-for-longer rate environment.
• Containerboard/OCC pricing and sector rotation: Basic Materials has been out of favor, and IP's margins are levered to containerboard price realizations against old-corrugated-container input costs.

• Q3 2026 earnings, expected late October 2026 - the first real test of whether the sequential revenue bleed has stopped and whether cost-out and price realization are showing up in margin rather than just in commentary.
• European operations separation: a spin/sale of the DS Smith-derived EMEA business would leave a higher-margin, North America-focused packaging pure-play and could delever the balance sheet - the single biggest value-unlock lever in the story.
• Footprint and integration milestones: Carrollton South packaging facility closure targeted by end of Q3 2026, and integration of the $360M NORPAC acquisition completed in late May 2026.
• Management's structural cost-reduction and portfolio-optimization program under CEO Andy Silvernail, which is intended to protect baseline margins even if volumes stay soft.
• Dividend policy signaling: at a 4.54% yield with trailing four-quarter FCF of only $492M, any commentary on dividend coverage versus capex will move the stock, in either direction.

• Dividend coverage: trailing four-quarter free cash flow of just $492M ($-7M in Q2 2026, $94M in Q1 2026, $255M in Q4 2025, $150M in Q3 2025) does not cover an estimated ~$826M annual dividend at the current yield - a cut would be a serious sentiment event.
• Persistent demand weakness: if management's own guidance of soft packaging demand through 2027 is right, the 25.2x forward P/E on $1.362 of EPS has substantial compression risk.
• European separation execution risk: splitting EMEA mid-integration is complex, and a delayed, poorly priced, or value-destructive separation would remove the main re-rating catalyst.
• Further impairment and restructuring charges: the Q3 2025 (-$1.10B net) and Q4 2025 (-$2.38B net) write-downs show how much carrying value is still exposed if the EMEA disposal or DS Smith integration assumptions change.
• Balance sheet and rate sensitivity: $8.22B of long-term debt against $726M of cash and a 1.098 current ratio leaves limited cushion if fuel, tariffs, and pricing all move the wrong way at once.
• Weather/operational disruption: the late-June 2026 temporary suspension at the Pine Hill, Alabama mill shows how quickly unplanned outages can dent an already-thin margin.

Not a buy at $34.36 as of 2026-09-13 - but not a short either. The bear case is simple: revenue is flat-to-down, management guides soft demand into 2027, the 4.54% dividend is not covered by trailing free cash flow, and the stock trades at 25x next-FY EPS with the shares below every moving average. The bull case is equally real: this is a cyclical at a trough whose reported numbers are buried under ~$3B of non-cash charges, the balance sheet is stable (1.098 current ratio, 1.26x book), and a successful European separation plus cost-out could plausibly support $2.65 of mid-cycle EPS, worth roughly $38.50 today and considerably more if the EMEA split re-rates a cleaner North American pure-play. My lean is Cautiously Bearish because the deterministic scoring framework lands there (Weak Fundamentals + Cheap vs. its own history) and because you are not being paid enough - roughly 12% to my fair value - to underwrite a turnaround that management itself says won't show in demand until 2027. Watch, don't chase; the late-October Q3 print is the decision point.

I built a mid-cycle normalized-earnings value: ~$24.5B normalized revenue at a 16.5% mid-cycle EBITDA margin (~$4.0B), less ~$1.7B of post-DS Smith D&A and ~$470M of net interest, taxed at 25%, gives ~$2.65 of normalized EPS on ~529M shares, which at a 14.5x mid-cycle multiple for a low-growth, moderately levered containerboard producer equals ~$38.50. That sits deliberately between the two outliers - the trough-based 25.2x forward P/E on $1.362 of FY+1 EPS (which would justify ~$34) and the sell-side's $48-50 targets, which require both a full cyclical recovery and a successful EMEA separation to be realized.